Product Information
SUFLAVE POWDER is a brand product labeled by Braintree Laboratories, Inc., priced at $61.6463 per EA under NDC 52268055001. Its NADAC has been published 155 times since Oct 18, 2023.
FDA first approved this application on Jun 15, 2023.
SUFLAVE POWDER
polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solutionManufacturer
Braintree Laboratories, Inc.NDC
52268055001
Classification
Brand
Dosage Form
KIT
Effective Date
6/17/2026
Approval Type
New Drug (NDA)
FDA Application
NDA215344FDA Approved
6/15/2023
On Market Since
6/15/2023
Price Statistics
The NADAC for SUFLAVE POWDER has been published 155 times since Oct 18, 2023, and over the history we have for it it has risen 4.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $61.6463 per EA |
|---|---|
| All-time high | $61.7751 (May 14, 2025) |
| All-time low | $59.0470 (Oct 18, 2023) |
| 52-week high | $61.6780 |
| 52-week low | $61.6285 |
| Median price | $61.6415 |
| Average price | $60.8166 |
| Largest weekly change | +3.0% (Jan 8, 2025) |
| Weeks tracked | 155 |
| Tracking since | Oct 18, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solution market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Braintree Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solution market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SUFLAVE POWDER?
The current National Average Drug Acquisition Cost (NADAC) for SUFLAVE POWDER, manufactured by Braintree Laboratories, Inc., is $61.6463 per EA (NDC 52268055001), effective Sep 30, 2026.
How has the price of SUFLAVE POWDER changed over time?
Over the history we have for it, the NADAC for SUFLAVE POWDER has risen 4.4%. It has been tracked across 155 weekly CMS publications since Oct 18, 2023.
What are the highest and lowest recorded NADAC prices for SUFLAVE POWDER?
Since Oct 18, 2023, the NADAC for SUFLAVE POWDER has ranged from a low of $59.0470 (Oct 18, 2023) to a high of $61.7751 (May 14, 2025), with a median of $61.6415 per EA.
Are there cheaper alternatives to SUFLAVE POWDER?
No other NADAC-published product currently shares the active ingredient and strength of SUFLAVE POWDER in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SUFLAVE POWDER?
SUFLAVE POWDER (NDC 52268055001) is labeled by Braintree Laboratories, Inc., and CMS classifies it as a brand product.